Lyell Immunopharma (LYEL) Short Interest Ratio & Short Volume $0.61 -0.03 (-5.12%) (As of 03:28 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lyell Immunopharma Short Interest DataLyell Immunopharma (LYEL) has a short interest of 9.45 million shares, representing 7.22% of the float (the number of shares available for trading by the public). This marks a -1.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 1.04 million shares to cover all short positions.Current Short Interest9,450,000 sharesPrevious Short Interest9,600,000 sharesChange Vs. Previous Month-1.56%Dollar Volume Sold Short$8.93 millionShort Interest Ratio7.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares292,162,000 sharesFloat Size130,850,000 sharesShort Percent of Float7.22%Today's Trading Volume1,097,859 sharesAverage Trading Volume1,041,483 sharesToday's Volume Vs. Average105% Short Selling Lyell Immunopharma? Sign up to receive the latest short interest report for Lyell Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYEL Short Interest Over TimeLYEL Days to Cover Over TimeLYEL Percentage of Float Shorted Over Time Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Lyell Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20249,450,000 shares $8.93 million -1.6%7.2%7.3 $0.95 11/15/20249,600,000 shares $10.56 million -13.8%7.7%7.7 $1.10 10/31/202411,140,000 shares $10.70 million +3.5%8.9%10.3 $0.96 10/15/202410,760,000 shares $12.59 million +0.9%9.4%17.1 $1.17 9/30/202410,660,000 shares $14.71 million -19.4%9.4%16 $1.38 9/15/202413,220,000 shares $16.26 million -3.9%11.6%13.8 $1.23 Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 8/31/202413,760,000 shares $19.95 million -8.5%12.1%14.6 $1.45 8/15/202415,030,000 shares $18.86 million -7.9%13.3%15.9 $1.26 7/31/202416,320,000 shares $26.28 million +1.2%13.6%16.9 $1.61 7/15/202416,130,000 shares $27.74 million -10.0%13.6%16.6 $1.72 6/30/202417,920,000 shares $25.98 million -25.8%15.1%16.9 $1.45 6/15/202424,150,000 shares $56.99 million +19.6%20.4%30.6 $2.36 5/31/202420,200,000 shares $55.95 million +0.5%17.1%25.2 $2.77 5/15/202420,100,000 shares $52.46 million +0.7%17.0%23.3 $2.61 4/30/202419,970,000 shares $43.33 million +9.5%16.9%22.3 $2.17 4/15/202418,230,000 shares $43.75 million +0.7%15.5%19.8 $2.40 3/31/202418,100,000 shares $40.36 million +74.4%15.5%18.8 $2.23 3/15/202410,380,000 shares $22.42 million -5.2%8.9%10.3 $2.16 2/29/202410,950,000 shares $31.97 million -39.6%9.4%8.9 $2.92 2/15/202418,130,000 shares $34.45 million +67.3%15.7%14.5 $1.90 1/31/202410,840,000 shares $19.84 million -30.6%9.4%8.2 $1.83 1/15/202415,620,000 shares $34.68 million +4.4%12.7%11.8 $2.22 12/31/202314,960,000 shares $29.02 million -13.2%12.1%12.2 $1.94 12/15/202317,240,000 shares $33.10 million -0.6%14.0%15.3 $1.92 11/30/202317,340,000 shares $30.00 million -2.3%14.1%18.8 $1.73 11/15/202317,740,000 shares $36.37 million -7.6%14.4%20.3 $2.05 10/31/202319,200,000 shares $31.78 million -7.3%15.8%25.1 $1.66 10/15/202320,720,000 shares $33.98 million -2.3%17.1%29.2 $1.64 9/30/202321,210,000 shares $31.18 million +1.3%17.5%30 $1.47 9/15/202320,930,000 shares $35.37 million -5.2%17.2%28.3 $1.69 8/31/202322,070,000 shares $52.75 million -3.7%18.3%24.3 $2.39 8/15/202322,910,000 shares $52.46 million -2.5%19.0%23 $2.29 7/31/202323,500,000 shares $67.92 million +1.5%19.6%22 $2.89 7/15/202323,160,000 shares $67.86 million -1.2%19.3%20.9 $2.93 6/30/202323,450,000 shares $74.57 million +3.9%19.6%20.8 $3.18 6/15/202322,580,000 shares $87.16 million +4.9%18.9%18.7 $3.86 5/31/202321,530,000 shares $68.68 million +2.8%18.0%20.1 $3.19 5/15/202320,950,000 shares $63.06 million +3.2%17.5%19.8 $3.01 4/30/202320,300,000 shares $41.21 million -0.7%17.0%20.1 $2.03 4/15/202320,450,000 shares $48.26 million -1.8%17.1%20.9 $2.36Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/202320,830,000 shares $49.16 million +1.3%17.4%20.2 $2.36 3/15/202320,560,000 shares $45.03 million +14.2%17.2%19.6 $2.19 2/28/202318,010,000 shares $38.72 million +5.4%15.1%16.2 $2.15 2/15/202317,080,000 shares $42.70 million -2.1%14.3%15.7 $2.50 1/31/202317,440,000 shares $57.03 million -2.9%14.6%15.2 $3.27 1/15/202317,960,000 shares $58.01 million -9.4%15.0%15.5 $3.23 12/30/202219,820,000 shares $68.78 million +15.8%20.3%18 $3.47 12/15/202217,110,000 shares $56.12 million -2.0%17.5%16.1 $3.28 11/30/202217,450,000 shares $73.46 million -5.7%22.0%15.3 $4.21 11/15/202218,510,000 shares $85.15 million -2.5%23.4%16.5 $4.60 10/31/202218,990,000 shares $111.66 million -1.1%23.4%18.6 $5.88 10/15/202219,200,000 shares $125.57 million +5.1%23.6%18.6 $6.54 9/30/202218,270,000 shares $133.92 million +19.3%22.5%18.6 $7.33 9/15/202215,320,000 shares $121.95 million +7.0%19.1%14.7 $7.96 8/31/202214,320,000 shares $95.94 million -7.2%18.1%15.6 $6.70 8/15/202215,430,000 shares $116.03 million -4.6%19.5%17.1 $7.52 7/31/202216,180,000 shares $90.12 million -4.9%25.4%17.1 $5.57 7/15/202217,010,000 shares $100.36 million -2.4%26.7%19.1 $5.90 6/30/202217,430,000 shares $113.64 million +6.9%27.4%19.3 $6.52 6/15/202216,310,000 shares $77.15 million +1.8%25.6%17.9 $4.73 5/31/202216,030,000 shares $66.36 million +5.6%25.4%13 $4.14 5/15/202215,180,000 shares $60.57 million -2.9%24.1%11.9 $3.99 4/30/202215,640,000 shares $80.23 million -6.0%26.4%12.3 $5.13 4/15/202216,630,000 shares $89.64 million +5.3%28.1%13 $5.39 3/31/202215,800,000 shares $79.79 million +29.7%26.7%12.3 $5.05 3/15/202212,180,000 shares $73.20 million +21.7%21.0%9 $6.01 2/28/202210,010,000 shares $72.47 million +6.0%17.3%11.3 $7.24 2/15/20229,440,000 shares $64.38 million +9.6%16.4%12.4 $6.82 1/31/20228,610,000 shares $48.90 million +2.7%14.9%12.9 $5.68 1/15/20228,380,000 shares $50.62 million +10.1%14.5%14.8 $6.04 12/31/20217,610,000 shares $58.90 million +22.4%13.2%15.1 $7.74 12/15/20216,220,000 shares $55.98 million +17.4%10.8%13 $9.00 11/30/20215,300,000 shares $50.62 million +7.1%9.9%12.1 $9.55 11/15/20214,950,000 shares $54.70 million No Change9.3%10.7 $11.05 10/29/20214,950,000 shares $69.00 million +3.8%9.2%11.5 $13.94 10/15/20214,770,000 shares $63.35 million +11.7%8.9%11 $13.28 9/30/20214,270,000 shares $63.20 million +10.3%8.0%9.1 $14.80 9/15/20213,870,000 shares $51.01 million +15.2%5.2%8.2 $13.18 8/31/20213,360,000 shares $53.05 million +10.2%4.4%7.1 $15.79 8/13/20213,050,000 shares $45.17 million No Change4.0%6.7 $14.81 LYEL Short Interest - Frequently Asked Questions What is Lyell Immunopharma's current short interest? Short interest is the volume of Lyell Immunopharma shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 9,450,000 shares of LYEL short. 7.22% of Lyell Immunopharma's shares are currently sold short. Learn More on Lyell Immunopharma's current short interest. What is a good short interest ratio for Lyell Immunopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYEL shares currently have a short interest ratio of 7.0. Learn More on Lyell Immunopharma's short interest ratio. What is a good short interest percentage for Lyell Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.22% of Lyell Immunopharma's floating shares are currently sold short. Is Lyell Immunopharma's short interest increasing or decreasing? Lyell Immunopharma saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 9,450,000 shares, a decline of 1.6% from the previous total of 9,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lyell Immunopharma's float size? Lyell Immunopharma currently has issued a total of 292,162,000 shares. Some of Lyell Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lyell Immunopharma currently has a public float of 130,850,000 shares. How does Lyell Immunopharma's short interest compare to its competitors? 7.22% of Lyell Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lyell Immunopharma: Immunome, Inc. (19.29%), Kura Oncology, Inc. (11.20%), Keros Therapeutics, Inc. (5.43%), Tyra Biosciences, Inc. (6.79%), Erasca, Inc. (19.73%), Cronos Group Inc. (1.72%), Evolus, Inc. (8.23%), Dianthus Therapeutics, Inc. (29.30%), Rapport Therapeutics (10.25%), Autolus Therapeutics plc (2.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Lyell Immunopharma stock? Short selling LYEL is an investing strategy that aims to generate trading profit from Lyell Immunopharma as its price is falling. LYEL shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyell Immunopharma? A short squeeze for Lyell Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYEL, which in turn drives the price of the stock up even further. How often is Lyell Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYEL, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies IMNM Short Squeeze KURA Short Squeeze KROS Short Squeeze TYRA Short Squeeze ERAS Short Squeeze CRON Short Squeeze EOLS Short Squeeze DNTH Short Squeeze RAPP Short Squeeze AUTL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYEL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LYEL Stock Alerts